Loring Wolcott & Coolidge Fiduciary Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-23,845
| Closed | -$2.37M | – | 746 |
|
|
2019
Q3 | $2.37M | Sell |
23,845
-17,352
| -42% | -$1.65M | 0.03% | 107 |
|
|
2019
Q2 | $3.81M | Sell |
41,197
-265,716
| -87% | -$25.2M | 0.06% | 92 |
|
|
2019
Q1 | $29M | Sell |
306,913
-664,850
| -68% | -$58.1M | 0.44% | 51 |
|
|
2018
Q4 | $62.3M | Sell |
971,763
-231,231
| -19% | -$17.1M | 1.13% | 30 |
|
|
2018
Q3 | $108M | Sell |
1,202,994
-15,241
| -1% | -$1.35M | 1.71% | 20 |
|
|
2018
Q2 | $96.8M | Sell |
1,218,235
-1,316
| -0.1% | -$109K | 1.68% | 19 |
|
|
2018
Q1 | $109M | Buy |
1,219,551
+89,509
| +8% | +$8.59M | 1.98% | 17 |
|
|
2017
Q4 | $118M | Buy |
1,130,042
+77,016
| +7% | +$8.69M | 2.17% | 16 |
|
|
2017
Q3 | $154M | Buy |
1,053,026
+35,846
| +4% | +$4.88M | 2.97% | 10 |
|
|
2017
Q2 | $138M | Buy |
1,017,180
+73,107
| +8% | +$8.96M | 2.74% | 10 |
|
|
2017
Q1 | $117M | Buy |
944,073
+49,400
| +6% | +$5.91M | 2.46% | 11 |
|
|
2016
Q4 | $104M | Buy |
894,673
+57,631
| +7% | +$6.42M | 2.31% | 12 |
|
|
2016
Q3 | $87.5M | Buy |
837,042
+51,173
| +7% | +$5.54M | 2% | 16 |
|
|
2016
Q2 | $77.5M | Buy |
785,869
+29,583
| +4% | +$3.06M | 1.78% | 20 |
|
|
2016
Q1 | $75.7M | Buy |
756,286
+134,634
| +22% | +$13.9M | 1.79% | 21 |
|
|
2015
Q4 | $74.4M | Buy |
621,652
+36,882
| +6% | +$4.27M | 1.84% | 20 |
|
|
2015
Q3 | $67.7M | Hold |
584,770
| – | – | 1.73% | 21 |
|
|
2015
Q2 | $67.7M | Sell |
584,770
-1,332
| -0.2% | -$152K | 1.73% | 21 |
|
|
2015
Q1 | $67.6M | Buy |
586,102
+22,806
| +4% | +$2.73M | 1.7% | 22 |
|
|
2014
Q4 | $63M | Sell |
563,296
-1,061
| -0.2% | -$112K | 1.61% | 23 |
|
|
2014
Q3 | $53.5M | Buy |
564,357
+8,647
| +2% | +$780K | 1.45% | 24 |
|
|
2014
Q2 | $47.7M | Buy |
555,710
+262,202
| +89% | +$19.9M | 1.29% | 27 |
|
|
2014
Q1 | $20.5M | Buy |
293,508
+196,880
| +204% | +$15.6M | 0.56% | 48 |
|
|
2013
Q4 | $8.16M | Buy |
96,628
+1,404
| +1% | +$111K | 0.23% | 72 |
|
|
2013
Q3 | $7.34M | Buy |
95,224
+5,660
| +6% | +$397K | 0.22% | 76 |
|
|
2013
Q2 | $5.24M | Buy |
+89,564
| New | +$5.39M | 0.16% | 93 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Loring Wolcott & Coolidge Fiduciary Advisors's CELG Position: Q4 2019 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 23,845 shares — an estimated $2.37M sold.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $154M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 23,845 Celgene Corp shares in Q4 2019, an estimated $2.37M.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Loring Wolcott & Coolidge Fiduciary Advisors's Celgene Corp position peaked at $154M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2019, filed 22 Jan 2020.